Evidence map›Paper›PMID 41545455›Full record

ArticleScientific reports2026

Green analytical method for determination of oxeladin citrate using advanced electrochemical modified sensors in pure form, pharmaceuticals, human serum and binary mixtures with guaifenesin.

Sherin F Hammad, Hassan A Hendawy, Hala M Habib

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sherin F HammadPharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Tanta University, Elgeish Street, Tanta, Egypt. Sherinhammad@pharm.tanta.edu.eg.
Hassan A HendawyEgyptian Drug Authority (EDA), Giza, Egypt.
Hala M HabibEgyptian Drug Authority (EDA), Giza, Egypt. halahabib045@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This work presents a selective, accurate, and highly sensitive differential pulse voltammetric (DPV) approach for the quantification of oxeladin citrate (OC). The electrochemical behavior of OC was investigated using several working electrodes, including carbon paste electrode (CPE), zeolite-modified carbon paste electrode (ZMCPE), iron oxide-modified carbon paste electrode (IOMCPE) and screen-printed multi-wall carbon nanotubes (SPMWCNTs), with operational parameters optimized through cyclic voltammetry. The results confirmed an irreversible, diffusion-controlled oxidation process for OC producing a peak between 0.7 and 0.8 V (vs. Ag/AgCl). The SPMWCNTs electrode outperformed the others, providing a linear calibration range from 0.35 to 3.9 μg/mL (R

Indexed as

Electrochemical TechniquesGreen Chemistry TechnologyGuaifenesinElectrodesHumansLimit of DetectionNanotubes, CarbonPharmaceutical PreparationsGuaifenesinNanotubes, CarbonPharmaceutical PreparationsCarbon paste electrodeGuaifenesinOxeladin CitrateScreen printedZeolite

Identifiers

PMID41545455
PMCPMC12820231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.